+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Chronic Refractory Cough - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Refractory Cough - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
From
Severe Asthma - Pipeline Insight, 2024 - Product Thumbnail Image

Severe Asthma - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 180 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Asthma - Pipeline Insight, 2024 - Product Thumbnail Image

Asthma - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Acute Respiratory Distress Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Respiratory Distress Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 180 Pages
  • Global
From
From
From
From
Emphysema Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Emphysema Treatment Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 250 Pages
  • Global
From
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more